Reaction

Renal Tubular Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,795 reports · 106 co-occurring drugs

As of the last recalculation, Renal Tubular Disorder appears in 2,795 FAERS reports alongside 106 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 74.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tenofovir Disoproxil Fumarate Tablets	84	74.7	75.4
Atazanavir	124	67.2	67.8
Ritonavir	196	53.6	54.0
Tenofovir Disoproxil Fumarate	215	52.4	52.7
Lopinavir And Ritonavir	92	52.2	52.6
Ifosfamide	107	38.5	38.7
Darunavir	76	38.4	38.6
Raltegravir	79	36.6	36.8
Abacavir Sulfate	46	35.7	35.9
Lamivudine	135	34.1	34.3
Ritonavir 100 Mg	59	30.0	30.1
Basiliximab	46	29.6	29.7
Emtricitabine And Tenofovir Disoproxil Fumarate	169	29.3	29.4
Lamivudine Oral	88	26.7	26.8
Mesna Injection	24	21.8	21.9
Mesna	24	21.4	21.5
Amphotericin B	35	21.1	21.1
Ganciclovir Sodium	29	20.6	20.7
Ganciclovir	28	20.6	20.6
Efavirenz	25	16.8	16.9
Piperacillin Sodium,Tazobactam Sodium	56	16.0	16.1
Dolutegravir Sodium	19	15.8	15.8
Pemetrexed	43	15.2	15.2
Gentamicin	26	14.9	15.0
Deferasirox	51	14.6	14.6
Nebivolol	30	14.2	14.2
Pemetrexed Disodium	70	14.0	14.0
Posaconazole	30	13.9	13.9
Gentamicin Sulfate	29	13.8	13.8
Valganciclovir Hydrochloride Powder,	22	13.5	13.6
Valganciclovir	33	13.2	13.2
Valganciclovir Hydrochloride	33	13.2	13.2
Azacitidine For	31	12.8	12.8
Etoposide	121	12.8	12.8
Entecavir	19	12.2	12.2
Sulfamethoxazole And Trimethoprim	123	11.3	11.3
Vancomycin	85	11.3	11.3
Vancomycin Hydrochloride	93	10.8	10.8
Nevirapine	13	10.8	10.8
Amikacin	24	10.6	10.6
Cisplatin	106	10.5	10.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	12	10.0	10.0
Micafungin Sodium	11	9.7	9.7
Carboplatin	154	9.5	9.5
Candesartan Cilexetil	33	9.4	9.5
Alemtuzumab	24	9.3	9.3
Azacitidine	36	9.1	9.2
Mycophenolate Mofetil	152	8.8	8.8
Mycophenolate Mofetil Hydrochloride	152	8.7	8.7
Tacrolimus	172	8.6	8.7
Anti-Thymocyte Globulin (Rabbit)	9	8.3	8.3
Iohexol	9	8.1	8.1
Melphalan	24	7.9	7.9
Tacrolimus Ointment 0.1%	123	7.6	7.7
Tacrolimus Extended-Release Capsules	123	7.6	7.6
Valacyclovir	42	7.6	7.6
Melphalan Hydrochloride	25	7.5	7.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	10	7.4	7.4
Nebivolol Hydrochloride	33	7.4	7.4
Valacyclovir Hydrochloride	67	7.2	7.2
Atropine	8	7.2	7.2
Posaconazole Delayed-Release	10	6.8	6.8
Zidovudine	12	6.7	6.7
Bleomycin Sulfate	9	6.5	6.5
Piperacillin And Tazobactam	11	6.4	6.4
Voriconazole	26	6.4	6.4
Busulfan	13	6.2	6.2
Lithium Carbonate	14	6.2	6.2
Piperacillin Sodium And Tazobactam Sodium	16	6.1	6.1
Sofosbuvir	16	6.1	6.1
Cefepime Hydrochloride	13	6.0	6.0
Cyclosporine	87	6.0	6.0
Fosaprepitant Dimeglumine	11	6.0	6.0
Emtricitabine And Tenofovir Alafenamide	9	5.9	5.9
Rifampicin	8	5.9	5.9
Cefepime	11	5.7	5.7
Granisetron Hydrochloride	8	5.7	5.7
Sirolimus	10	5.5	5.5
Voriconazole Injection	16	5.5	5.5
Cetuximab	23	5.5	5.5
Dapagliflozin	23	5.5	5.5
Valproic Acid	23	5.5	5.5
Thiotepa	7	5.5	5.5
Everolimus Tablets	12	5.3	5.4
Aprepitant	13	5.3	5.3
Meropenem	21	4.9	4.9
Durvalumab	13	4.8	4.8
Pembrolizumab	64	4.6	4.6
Panitumumab	9	4.3	4.3
Granisetron	6	4.3	4.3
Acyclovir	64	4.2	4.2
Daptomycin	5	4.0	4.0
Fludarabine Phosphate	20	3.8	3.8
Paclitaxel (Aibumin-Bound)	40	3.7	3.7
Sevoflurane	4	3.6	3.6
Doxorubicin	41	3.5	3.5
Doxorubicin Hydrochloride	15	3.4	3.4
Miconazole Nitrate	4	3.4	3.4
Paclitaxel	44	3.3	3.3
Fluorouracil Cream, 0.5%	32	3.1	3.1
Ledipasvir And Sofosbuvir	8	3.1	3.1
Encorafenib	4	3.0	3.0
Atezolizumab	14	2.7	2.7
Vemurafenib	4	2.5	2.5
Dornase Alfa	6	2.3	2.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	2.1	2.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.